Buy & Sell Adaptive Biotechnologies Corp (ADPT) – Adaptive Biotechnologies Corp Price Today
Key Stats
- $2.28BMarket Cap
- HealthSector
- -35.47%3M Drawdown
- $2.13BEnterprise Value
- -Dividend Yield
- 32 daysTypical Hold Time
Adaptive Biotechnologies Corp (ADPT) is currently valued at a market capitalization of $2.28B, with an enterprise value of $2.13B. Over the past 52 weeks, Adaptive Biotechnologies Corp has traded between a low of $6.83 and a high of $20.46, highlighting its annual price range. Over the past three months, Adaptive Biotechnologies Corp has recorded a drawdown of -35.47%, reflecting recent price volatility. Adaptive Biotechnologies Corp offers a dividend yield of -. On average, investors hold Adaptive Biotechnologies Corp for approximately 32 days, indicating typical investor behavior on the platform.
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
